Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical spectrum of ocular lymphoma.
Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. Peterson K, et al. Among authors: gordon kb. Cancer. 1993 Aug 1;72(3):843-9. doi: 10.1002/1097-0142(19930801)72:3<843::aid-cncr2820720333>3.0.co;2-#. Cancer. 1993. PMID: 8334638
Late effects of radiation on the eye and ocular adnexa.
Gordon KB, Char DH, Sagerman RH. Gordon KB, et al. Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1123-39. doi: 10.1016/0360-3016(95)00062-4. Int J Radiat Oncol Biol Phys. 1995. PMID: 7713778 Review.
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.
Armstrong AW, Foley P, Liu Y, Miller M, Teneralli RE, Bewley A, Gordon KB, Papp KA, Han C. Armstrong AW, et al. Among authors: gordon kb. Dermatol Ther (Heidelb). 2024 Sep;14(9):2577-2589. doi: 10.1007/s13555-024-01250-9. Epub 2024 Aug 23. Dermatol Ther (Heidelb). 2024. PMID: 39177870 Free PMC article.
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.
Armstrong AW, Augustin M, Beaumont JL, Pham TP, Hudgens S, Gordon KB, Zhuo J, Becker B, Zhong Y, Kisa RM, Banerjee S, Papp KA. Armstrong AW, et al. Among authors: gordon kb. Dermatol Ther (Heidelb). 2024 Aug;14(8):2235-2248. doi: 10.1007/s13555-024-01224-x. Epub 2024 Jul 30. Dermatol Ther (Heidelb). 2024. PMID: 39080153 Free PMC article.
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?
Boswell ND, Singla S, Gordon KB. Boswell ND, et al. Among authors: gordon kb. Am J Clin Dermatol. 2024 Sep;25(5):795-810. doi: 10.1007/s40257-024-00874-z. Epub 2024 Jul 13. Am J Clin Dermatol. 2024. PMID: 39003351 Review.
Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2.
Blauvelt A, Gordon KB, Langley RG, Branigan PJ, Chen Y, Miller M, Han C, Fakharzadeh S, Muñoz-Elías EJ, Armstrong AW. Blauvelt A, et al. Among authors: gordon kb. J Invest Dermatol. 2024 Dec;144(12):2816-2819.e2. doi: 10.1016/j.jid.2024.05.020. Epub 2024 Jun 25. J Invest Dermatol. 2024. PMID: 38936766 Free article. No abstract available.
180 results